文献速递痛风与晶体性关节病自身炎症与 IgG4 相关病

基于TNFRSF11B突变的新型早期焦磷酸钙沉积病小鼠模型再现人类疾病特征

A novel murine model of early calcium pyrophosphate deposition disease based on the TNFRSF11B mutation mimics features of the human disease.
PubMed 文献 · Ann Rheum Dis · 2026-03-12

本研究利用CRISPR/Cas9编辑生成携带TNFRSF11B突变(Opgmt)的小鼠,在6和12月龄评估骨与关节表型及焦磷酸钙沉积病(CPPD)生物标志物。携带Opgmt的雌雄小鼠均出现骨量减少和高骨转换标志物,雌性Opgmt/mt小鼠12月龄出现显著骨关节炎特征,且关节内焦磷酸、TGF-β1和ENPP1活性显著升高。Opgmt小鼠再现了人类早期CPPD的骨与关节表型,可作为临床前模型。

要点

  • Opgmt小鼠在6和12月龄出现骨量减少和高骨转换标志物。
  • 雌性Opgmt/mt小鼠12月龄出现显著骨关节炎特征。
  • 雌性Opgmt小鼠关节内焦磷酸、TGF-β1和ENPP1活性显著升高。

核心结论

  • 携带Opgmt的小鼠表现出人类早期CPPD病的骨与关节表型,是研究早期CPPD治疗的新型临床前模型。

研究设计与样本

  • 使用CRISPR/Cas9编辑生成携带TNFRSF11B突变的小鼠(Opgmt),在6和12月龄比较野生型(Opgwt/wt)、杂合子(Opgwt/mt)和纯合子(Opgmt/mt)小鼠的关节与骨表型、骨重塑生物标志物及CPPD关键生物标志物。

主要发现

  • 携带Opgmt的雄性和雌性小鼠在6和12月龄均出现骨量减少和高骨重塑标志物,并伴有破骨细胞数量和活性增加。
  • 雌性Opgmt/mt小鼠在12月龄出现显著骨关节炎特征,包括基于Mankin结构损伤评分的膝关节外侧间室关节软骨丢失。
  • 在6和12月龄雌性Opgmt小鼠的关节中,CPPD病特征性生物标志物如焦磷酸、转化生长因子(TGF)-β1水平和ENPP1活性均显著升高。

临床怎么用

  • Opgmt小鼠可用于探索在主要关节损伤发生前靶向早期CPPD病的潜在疗法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Calcium pyrophosphate deposition (CPPD) disease is a common form of arthritis affecting older individuals. This disease is characterised by high levels of pyrophosphate in articular cartilage, resulting in calcium pyrophosphate crystal formation in humans and inflammatory and degenerative arthritis. A loss-of-function mutation in the TNFRSF11B locus (also known as CCAL1), which encodes osteoprotegerin (OPG) causes familial CPPD. OPG acts as a decoy receptor for RANKL, thereby inhibiting osteoclast differentiation and activity. CPPD currently lacks any animal models. The goal of this study was to develop a murine model of early CPPD by incorporating the TNFRSF11B gene mutation in mice and determining its effects on bones, joints and CPPD biomarkers. METHODS: We used CRISPR/Cas9 editing to generate mice carrying the TNFRSF11B mutation (Opgmt). Joint and bone phenotypes, bone remodelling biomarkers and key CPPD biomarkers were assessed in wild type (WT; Opgwt/wt), Opgwt/mt and Opgmt/mt mice at 6 and 12 months of age. RESULTS: Male and female mice carrying Opgmt displayed osteopenia and high bone remodelling markers at 6 and 12 months of age. This phenotype was concurrent with increased osteoclast numbers and activity. Female Opgmt/mt mice also displayed significant osteoarthritis features by 12 months of age, including articular cartilage loss in the lateral compartment of the knee based on Mankin structural damage scores. Additionally, biomarkers pathognomonic of CPPD disease, such as pyrophosphate, transforming growth factor (TGF)-β1 levels and ENPP1 activity, were significantly elevated in the joints of both 6- and 12-month-old female mice with OPGmt. CONCLUSIONS: Mice carrying Opgmt display bone and joint phenotypes characteristic of early-stage CPPD disease in humans. Opgmt mice represent a novel preclinical model of early CPPD, ideal for exploring potential therapies targeting the disease prior to the development of major joint damage.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Wang C, Gohr CM, Mitton-Fitzgerald E, et al. A novel murine model of early calcium pyrophosphate deposition disease based on the TNFRSF11B mutation mimics features of the human disease. Ann Rheum Dis. 2026. PMID: 41826214. doi:10.1016/j.ard.2026.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。